scholarly journals QIAGEN TherascreenKRASRGQ Assay, QIAGENKRASPyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis ofKRASMutations in Tumor Specimens

2016 ◽  
Vol 47 (1) ◽  
pp. 30-38 ◽  
Author(s):  
Qamra M. Alqahtani ◽  
Ann Crowley ◽  
Sharleen Rapp ◽  
Allison M. Cushman-Vokoun
1966 ◽  
Vol 39 (4) ◽  
pp. A-46-A-56
Author(s):  
Ellis S. Benson ◽  
Robert G. Martinek

2011 ◽  
Vol 20 (1) ◽  
pp. 27-32 ◽  
Author(s):  
Elaine A Sugarman ◽  
Narasimhan Nagan ◽  
Hui Zhu ◽  
Viatcheslav R Akmaev ◽  
Zhaoqing Zhou ◽  
...  

2009 ◽  
Vol 18 (3) ◽  
pp. 224-230 ◽  
Author(s):  
Anna Shearer ◽  
Marilyn Boehmer ◽  
Melanie Closs ◽  
Rosalina Dela Rosa ◽  
Jean Hamilton ◽  
...  

Background Blood from central venous or arterial catheters as well as from fingersticks is often used for point-of-care glucose testing.Objectives To compare glucose values obtained with a point-of-care device for catheter and fingerstick blood samples with values obtained by clinical laboratory analysis of a catheter blood sample.Methods A method-comparison design was used. Point-of-care values for fingerstick and catheter blood samples were compared with laboratory values for blood from catheters in a convenience sample of 63 critically ill patients. Device bias and precision were calculated and graphed according to the Bland-Altman method, and a t test was used to determine differences in glucose values for the 2 methods.Results Laboratory glucose values for blood from a catheter sample differed significantly from point-of-care values for blood from a fingerstick (t1,61 = 5.01; P < .001) and from a catheter (t1,61 = 3.91; P < .001). Bias and precision for the point-of-care device was large (fingerstick, 8.7 and 13.7; catheter, 7.0 and 14.0); 20% of the values differed from the laboratory glucose values by more than 20 mg/dL. Point-of-care glucose values for fingerstick and catheter samples did not differ (P = .41).Conclusions Glucose values obtained with a point-of-care device differ significantly from those obtained by laboratory analysis. The magnitude of these differences calls into question the widespread practice of using point-of-care glucose testing to guide insulin titration for tight glucose control. Errors in dosing could easily be made because of the large bias and precision associated with a point-of-care device.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Еmiliya Georgieva ◽  
Silvia Angelova ◽  
Minko Milev ◽  
Yuliyan Kostadinov ◽  
Plamen Russev

Sign in / Sign up

Export Citation Format

Share Document